Overview
Yuichi Taneyama practices practicing medicine in Chiba, Japan.
Taneyama is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Rosai-Dorfman Disease, Acute Monoblastic Leukemia (AmoL), Acute Lymphoblastic Leukemia (ALL), and Leukemoid Reaction.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yuichi Taneyama
Is Yuichi Taneyama a top-rated expert for Rosai-Dorfman Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Yuichi Taneyama is classified as an Advanced expert for Rosai-Dorfman Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yuichi Taneyama participate in research or clinical trials?
Yes. Yuichi Taneyama has published 12 articles and abstracts on conditions like Rosai-Dorfman Disease. You can view a list of Yuichi Taneyama's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Rosai-Dorfman DiseaseTaneyama isAdvanced. Learn about Rosai-Dorfman Disease.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Taneyama isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Taneyama isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Burkitt LymphomaTaneyama isExperienced. Learn about Burkitt Lymphoma.
- Down SyndromeTaneyama isExperienced. Learn about Down Syndrome.
- HistiocytosisTaneyama isExperienced. Learn about Histiocytosis.
- LeukemiaTaneyama isExperienced. Learn about Leukemia.
- Leukemoid ReactionTaneyama isExperienced. Learn about Leukemoid Reaction.
- Non-Langerhans-Cell HistiocytosisTaneyama isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- Progressive Multifocal Leukoencephalopathy
- ReticulohistiocytomaTaneyama isExperienced. Learn about Reticulohistiocytoma.
- Secondary Immunodeficiency (SID)Taneyama isExperienced. Learn about Secondary Immunodeficiency (SID).